Dasher Neuroscience

Pharma

Cipla Receives FDA Nod for Generic Advair Diskus

MUMBAI, India and WARREN, N.J., July 28, 2026 Cipla Limited and its wholly owned subsidiary Cipla USA Inc. have...

By cGxPwire Editor
July 30, 2026

.VC

CORE Biomedicine Secures $21M Series A Funding

BOSTON, TOKYO and SUZHOU, July 28, 2026 CORE Biomedicine, a biotechnology company advancing lineage-based precision oncology therapeutics, has announced...

By cGxPwire Editor
July 30, 2026

MedTech

Co-Diagnostics Advances Ebola Testing Innovation Globally

SALT LAKE CITY, July 28, 2026 Co-Diagnostics, Inc. has announced two significant milestones that strengthen global preparedness against Ebola...

By cGxPwire Editor
July 30, 2026

Bio-Pharma

Dasher Neuroscience Advances YA-101 Phase 2 Trial

TAIPEI, July 28, 2026 Dasher Neuroscience Holdings Inc. has successfully completed patient enrollment in its global Phase 2 clinical...

By cGxPwire Editor
July 29, 2026

We work Hard to get you posted with latest updates

Unwrap our new Directory

Dasher Neuroscience

Cipla Receives FDA Nod for Generic Advair Diskus

CORE Biomedicine Secures $21M Series A Funding

Co-Diagnostics Advances Ebola Testing Innovation Globally

Dasher Neuroscience Advances YA-101 Phase 2 Trial